Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/srep15460 http://scihub22266oqcxt.onion/10.1038/srep15460 C4614261!4614261!26486090     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Rep 2015 ; 5 (ä): ä Nephropedia Template TP {{tp|p=26486090|t=2015. Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies |pdf=|usr=}}{{26486090}} gab.com Text Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies JO: Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=26486090 #FOAvip Although there is evidence that non-steroidal anti-inflammatory drugs (NSAIDs) might be able to prevent pancreatic cancer, the findings from epidemiological studies have been inconsistent. In this paper, we conducted a meta-analysis of observational studies to examine this possibility. We searched PubMed and Embase for observational (cohort or case-control) studies examining the consumption of aspirin and other NSAIDs and the incidence of or mortality rates associated with pancreatic cancer. Twelve studies including approximately 258,000 participants in total were analysed. The administration of aspirin significantly reduced the incidence of pancreatic cancer (8 studies; odds ratio (OR)?=?0.77; 95% confidence interval (CI)?=?0.62 to 0.96; I2?=?74.2%) but not the mortality associated with it (2 studies; OR?=?0.94; 95% CI?=?0.73 to 1.22). Specifically, frequent aspirin use was associated with reduced pancreatic cancer incidence (OR?=?0.57; 95% CI?=?0.39 to 0.83 for high frequency; OR?=?0.57; 95% CI?=?0.38 to 0.84 for medium frequency). The summary ORs regarding the incidence of pancreatic cancer and either non-aspirin NSAIDs use (OR?=?1.08; 95% CI?=?0.90 to 1.31) or overall NSAIDs use (OR?=?0.97; 95% CI?=?0.86 to 1.10) were not significant. In conclusion, aspirin use might reduce the incidence of pancreatic cancer; however, this finding should be interpreted with caution because of study heterogeneity. Twit Text FOAVip Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies ????Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=26486090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26486090 #FOAvip English Wikipedia <ref>{{Cite pmid|26486090}}</ref> Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies #MMPMID26486090 Zhang YP; Wan YD; Sun YL; Li J; Zhu RT Sci Rep 2015[]; 5 (ä): ä PMID26486090show ga Although there is evidence that non-steroidal anti-inflammatory drugs (NSAIDs) might be able to prevent pancreatic cancer, the findings from epidemiological studies have been inconsistent. In this paper, we conducted a meta-analysis of observational studies to examine this possibility. We searched PubMed and Embase for observational (cohort or case-control) studies examining the consumption of aspirin and other NSAIDs and the incidence of or mortality rates associated with pancreatic cancer. Twelve studies including approximately 258,000 participants in total were analysed. The administration of aspirin significantly reduced the incidence of pancreatic cancer (8 studies; odds ratio (OR)?=?0.77; 95% confidence interval (CI)?=?0.62 to 0.96; I2?=?74.2%) but not the mortality associated with it (2 studies; OR?=?0.94; 95% CI?=?0.73 to 1.22). Specifically, frequent aspirin use was associated with reduced pancreatic cancer incidence (OR?=?0.57; 95% CI?=?0.39 to 0.83 for high frequency; OR?=?0.57; 95% CI?=?0.38 to 0.84 for medium frequency). The summary ORs regarding the incidence of pancreatic cancer and either non-aspirin NSAIDs use (OR?=?1.08; 95% CI?=?0.90 to 1.31) or overall NSAIDs use (OR?=?0.97; 95% CI?=?0.86 to 1.10) were not significant. In conclusion, aspirin use might reduce the incidence of pancreatic cancer; however, this finding should be interpreted with caution because of study heterogeneity. äAspirin might reduce the incidence of pancreatic cancer: A meta-analys(epmc).pdf DeepDyve Pubget Overpricing